Article
IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research - 1 Mar 2011
Lotrich Francis E, Loftis Jennifer M, Ferrell Robert E, Rabinovitz Mordechai, Hauser Peter
Abstract excerpt
Interferon-α (IFN-α) treatment for hepatitis C virus (HCV) is complicated by depression and related neurovegetative side effects. Recent genome-wide scans identified IL28B gene polymorphisms that associated with HCV clearance. Whether the IL28B polymorphism is also associated with these adverse effects of IFN-α would affect its clinical usefulness. One hundred thirty-three patients were prospectively examined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
